The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-((R)-1-(6-amino-9H-purin-9-yl)-2-oxoethoxy)-3-oxopropyl trihydrogen diphosphate ID: ALA4277262
Chembl Id: CHEMBL4277262
Cas Number: 64060-84-0
PubChem CID: 5491933
Max Phase: Preclinical
Molecular Formula: C10H13N5O10P2
Molecular Weight: 425.19
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1ncnc2c1ncn2[C@@H](C=O)O[C@@H](C=O)COP(=O)(O)OP(=O)(O)O
Standard InChI: InChI=1S/C10H13N5O10P2/c11-9-8-10(13-4-12-9)15(5-14-8)7(2-17)24-6(1-16)3-23-27(21,22)25-26(18,19)20/h1-2,4-7H,3H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t6-,7+/m0/s1
Standard InChI Key: NVPIJHRHNNQNDN-NKWVEPMBSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 425.19Molecular Weight (Monoisotopic): 425.0138AlogP: -1.08#Rotatable Bonds: 10Polar Surface Area: 226.28Molecular Species: ACIDHBA: 12HBD: 4#RO5 Violations: 1HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 1.77CX Basic pKa: 4.89CX LogP: -4.51CX LogD: -7.37Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.26Np Likeness Score: 0.59
References 1. Lee SY, Müller CE.. (2017) Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors., 8 (5): [PMID:30108800 ] [10.1039/C7MD00015D ] 2. Lee SY, Namasivayam V, Boshta NM, Perotti A, Mirza S, Bua S, Supuran CT, Müller CE.. (2021) Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy., 12 (7.0): [PMID:34355184 ] [10.1039/D1MD00117E ]